David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about the medication Vascepa.
800-TEMPLE-MED
Request Appointment
SEARCH TEMPLE HEALTH
Related News
Dr. Mohammed Chowdhury Provides Perspective to MedPage Today on New Drug to Prevent Worsening Pulmonary Arterial Hypertension
Posted August 6, 2026Data found oral ralinepag significantly reduced the risk of first clinical worsening in low-risk patients with pulmonary arterial hypertension already receiving contemporary background therapy.
Read MoreDr. Mohammed Chowdhury Discusses With ConsultantLive Presentation on Pulmonary Hypertension Screening With AI
Posted July 31, 2026Mohammed Andaleeb Chowdhury, MD, spoke with ConsultantLive and HCPLive about his presentation at the Pulmonary Hypertension Association International PH Conference and Scientific Sessions.
Read More